BBIO7:30 AMBridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9bridgebio.com
BBIO9:30 AMAcoramidis Continues to Demonstrate Disease-Modifying Effects in ATTR-CM, Reducing sTTR Variability and Outpatient Worsening Heart Failurebridgebio.com
BBIO4:01 PMBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)bridgebio.com
BBIO7:30 AMBEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazilbridgebio.com
BBIO7:30 AMBridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECEPresentation / Abstract • Phase 3bridgebio.com
BBIO7:30 AMBridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026Presentation / Abstractbridgebio.com
BBIO7:30 AMBridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4:30 pm ETbridgebio.com
BBIO7:30 AMBridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. Whitebridgebio.com
BBIO7:30 AMBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)bridgebio.com
BBIO3:30 PMAcoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54bridgebio.com
BBIO7:30 AMBridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9bridgebio.com
BBIO7:30 AMBridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific SessionsPresentation / Abstractbridgebio.com
BBIO4:01 PMBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)bridgebio.com
BBIO2:00 PMBBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9Interim Data • Phase 3bridgebio.com
BBIO7:30 AMBridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conferencebridgebio.com